SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-082212
Filing Date
2021-03-16
Accepted
2021-03-16 08:30:32
Documents
14
Period of Report
2021-03-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d128514d8k.htm   iXBRL 8-K 32240
2 EX-99.1 d128514dex991.htm EX-99.1 14056
6 GRAPHIC g128514g0313040945510.jpg GRAPHIC 2440
  Complete submission text file 0001193125-21-082212.txt   170789

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cydy-20210311.xsd EX-101.SCH 3067
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cydy-20210311_lab.xml EX-101.LAB 16084
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cydy-20210311_pre.xml EX-101.PRE 10119
7 EXTRACTED XBRL INSTANCE DOCUMENT d128514d8k_htm.xml XML 3002
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 21743731
SIC: 2834 Pharmaceutical Preparations